Literature DB >> 5417110

[Treatment of carcinoma and precancerosis using 5-fluorouracil].

E Landes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5417110

Source DB:  PubMed          Journal:  Arch Klin Exp Dermatol        ISSN: 0300-8614


× No keyword cloud information.
  7 in total

1.  SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL.

Authors:  C J DILLAHA; G T JANSEN; W M HONEYCUTT; A C BRADFORD
Journal:  Arch Dermatol       Date:  1963-09

2.  TUMORS OF THE SKIN. IV. DOUBLE-BLIND STUDY ON EFFECTS OF LOCAL ADMINISTRATION OF ANTI-TUMOR AGENTS IN BASAL CELL CARCINOMA.

Authors:  E KLEIN; H L STOLL; H MILGROM; R W CASE; H L TRAENKLE; S GRAHAM; Y LAOR; F HELM
Journal:  J Invest Dermatol       Date:  1965-05       Impact factor: 8.551

3.  [ON THE VALUE OF LOCAL CYTOSTATIC TREATMENT OF SKIN TUMORS].

Authors:  C G SCHIRREN; L GRUBER
Journal:  Munch Med Wochenschr       Date:  1964-11-13

4.  Tumors of the skin. II. Keratoacanthoma; local effct of 5-fluorouracil.

Authors:  E KLEIN; F HELM; H MILGROM; H L STOLL; H L TRAENKLE
Journal:  Skin (Los Angeles)       Date:  1962-06

5.  Untoward response with topical fluorouracil.

Authors:  W M Sams
Journal:  Arch Dermatol       Date:  1968-01

6.  Further studies with topical 5-fluorouracil.

Authors:  C J Dillaha; G T Jansen; W M Honeycutt; G A Holt
Journal:  Arch Dermatol       Date:  1965-10

7.  Tumors of the skin. V. Local administration of anti-tumor agents to multiple superficial basal cell carcinomas.

Authors:  E Klein; H L Stoll; H Milgrom; H L Traenkle; R W Case; Y Laor; F Helm; R S Nadel
Journal:  J Invest Dermatol       Date:  1965-12       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.